News

IHS Publishes COVID-19 Vaccination Plan

Task Force considers a potential vaccine “the most promising intervention” for its patient population.


 

COVID-19 infection rates have been nearly 4 times higher among American Indians/Alaska Natives (AI/ANs) when compared with those of non-Hispanic Whites, and AI/ANs are more than 4 times more likely to be hospitalized with the virus. Some mitigation measures have been harder to maintain in Native American communities. Frequent handwashing is difficult when water is at a premium, and social distancing is not always possible when extended families—including elderly—may be living in a single residence.

So vaccination “remains the most promising intervention,” the Indian Health Service Vaccine Task Force wrote in its COVID-19 Pandemic Vaccine Plan, released in November. The plan details how the IHS health care system will prepare for and distribute a vaccine when one becomes available in the US.

The Vaccine Task Force was established by the IHS Headquarters Incident Command Structure, which was activated in early March to respond to COVID-19. In September, the US Department of Health and Human Services (HHS) began a series of consultations with tribes and urban Indian organizations for input on the plan, which aligns as well with recommendations from the Centers for Disease Control and Prevention (CDC).

To “ensure that vaccines are effectively delivered throughout Indian Country in ways that make sense for tribal communities,” HHS Secretary Alex Azar says the Trump Administration has given all tribal health programs and urban Indian organizations two ways to receive the vaccine: through the IHS or through the state.

The CDC, along with IHS, states, and tribes, are coordinating the distribution of a vaccine for federal sites, tribal health programs, and Urban Indian Organizations (UIOs). CDC has issued data requirements that all health care facilities must meet for COVID-19 vaccine administration, inventory, and monitoring.

“There are system-wide planning efforts in place to make sure we’re ready to implement vaccination activities as soon as a US Food and Drug Administration authorized or approved vaccine is available,” said IHS Director RADM Michael Weahkee in a press release. The program’s success, he said, depends on “the strong partnership between the federal government, tribes, and urban leaders.”

The list of IHS, tribal health programs, and UIOs facilities that will receive the COVID-19 vaccine from the IHS, broken down by IHS area, is available on the IHS coronavirus website .

Recommended Reading

COVID-19–related outcomes poor for patients with hematologic disease in ASH registry
Federal Practitioner
PPE shortage crisis continues at most hospitals, survey shows
Federal Practitioner
COVID-19 fuels surge in overdose-related cardiac arrests
Federal Practitioner
COVID-19 and risk of clotting: ‘Be proactive about prevention’
Federal Practitioner
Demand for COVID vaccines expected to get heated – and fast
Federal Practitioner
Upper GI bleeds in COVID-19 not related to increased mortality
Federal Practitioner
Extended virus shedding after COVID-19 in some patients with cancer
Federal Practitioner
Can a health care worker refuse the COVID-19 vaccine?
Federal Practitioner
Patients with lung and blood cancers most vulnerable to COVID-19
Federal Practitioner
HCPs and COVID-19 Risk: Safer at Home or at Work?
Federal Practitioner